The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Open accessAbstract
Increased nonesterified fatty acid (NEFA) levels may be important in causing insulin resistance in skeletal muscles in patients with non-insulin-dependent diabetes mellitus (NIDDM). The acute effect of the antilipolytic nicotinic acid analogue Acipimox (2 X 250 mg) on basal and insulin-stimulated (3 h, 40 mU/m2 per min) glucose metabolism was therefore studied in 12 patients with NIDDM. Whole-body glucose metabolism was assessed using [3-3H]glucose and indirect calorimetry. Biopsies were taken from the vastus lateralis muscle during basal and insulin-stimulated steady-state periods. Acipimox reduced NEFA in the basal state and during insulin stimulation. Lipid oxidation was inhibited by Acipimox in all patients in the basal state (20 +/- 2 vs. 33 +/- 3 mg/m2 per min, P less than 0.01) and during insulin infusion (8 +/- 2 vs. 17 +/- 2 mg/m2 per min, P less than 0.01). Acipimox increased the insulin-stimulated glucose disposal rate (369 +/- 49 vs. 262 +/- 31 mg/m2 per min, P less than 0.01), whereas the glucose disposal rate was unaffected by Acipimox in the basal state. Acipimox increased glucose oxidation in the basal state (76 +/- 4 vs. 50 +/- 4 mg/m2 per min, P less than 0.01). During insulin infusion Acipimox increased both glucose oxidation (121 +/- 7 vs. 95 +/- 4 mg/m2 per min, P less than 0.01) and nonoxidative glucose disposal (248 +/- 47 vs. 167 +/- 29 mg/m2 per min, P less than 0.01). Acipimox enhanced basal and insulin-stimulated muscle fractional glycogen synthase activities (32 +/- 2 vs. 25 +/- 3%, P less than 0.05, and 50 +/- 5 vs. 41 +/- 4%, P less than 0.05). Activities of muscle pyruvate dehydrogenase and phosphofructokinase were unaffected by Acipimox. In conclusion, Acipimox acutely improved insulin action in patients with NIDDM by increasing both glucose oxidation and nonoxidative glucose disposal. This supports the hypothesis that elevated NEFA concentrations may be important for the insulin resistance in NIDDM. The mechanism responsible for the increased insulin-stimulated nonoxidative glucose disposal may be a stimulatory effect of Acipimox on glycogen synthase activity in skeletal muscles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, reduction of plasma FFA concentration in insulin resistant individuals, for example, type 2 diabetic subjects, augments insulin-stimulated glucose disposal in skeletal muscle [69–72], and the improvement in insulin sensitivity is closely associated with a reduction in intramyocellular FACoA concentration [69].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
A Flexible System of Enzymatic Analysis
Lowry, O. H., & Passonneau, J. V. (1972) · Elsevier eBooks · doi:10.1016/b978-0-12-457950-7.x5001-3 · Cited by 4,050
Calculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. D. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,680
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,604
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,198
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Research works printed but not linked: 1
- Passonneau, J. V. 1974. L-(+)-lactate: fluorometric method. In Methods ofEnzymatic Analysis. Volume 3. H. V. Bergmeyer, editor. Academic Press, Inc. New York. 1468-1472.
Cited by
Sorted by citations
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
Interaction between glucose and free fatty acid metabolism in human skeletal muscle.
Kelley, D. E., Mokáň, M., Simoneau, J. A., & Mandarino, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116603 · Cited by 480
Adipocyte lipolysis and insulin resistance
Morigny, P., Houssier, M., Mouisel, É., & Langin, D. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.024 · Cited by 504
Vaag, A., Henriksen, J. E., & Beck-Nielsen, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115656 · Cited by 299
Self-citationRoden, M., Stingl, H., Chandramouli, V, Schumann, W. C., Hofer, A., Landau, B. R., Nowotny, P., Waldhäusl, W., & Shulman, G. I. (2000) · Diabetes · doi:10.2337/diabetes.49.5.701 · Cited by 288
Impact of short‐term high‐fat feeding on glucose and insulin metabolism in young healthy men
Brøns, C., Jensen, C. B., Storgaard, H., Hiscock, N. J., White, A., Appel, J. S., Jacobsen, S., Nilsson, E., Larsen, C. M., Astrup, A. V., et al. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.169078 · Cited by 278
Self-citationFree fatty acids, insulin resistance, and type 2 diabetes mellitus
Boden, G. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99220.x · Cited by 246
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Gerich, J. E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80207-1 · Cited by 224
Glucose fatty acid interactions and the regulation of glucose disposal
Randle, P. J., Priestman, D. A., Mistry, S. C., & Halsall, A. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550002 · Cited by 199
Fatty acid metabolism, energy expenditure and insulin resistance in muscle
Turner, N. A., Cooney, G. J., Kraegen, E. W., & Bruce, C. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0397 · Cited by 206
How Free Fatty Acids Inhibit Glucose Utilization in Human Skeletal Muscle
Roden, M. (2004) · Physiology · doi:10.1152/nips.01459.2003 · Cited by 195
Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G. W., Mandarino, L. J., Shulman, G. I., & DeFronzo, R. A. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3148 · Cited by 181
Hew, F. L., Koschmann, M., Christopher, M., Rantzau, C., Vaag, A. A., Ward, G. M., Beck‐Nielsen, H., & ALFORD, F. P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636267 · Cited by 168
Self-citationMechanisms modifying glucose oxidation in diabetes mellitus
Randle, P. J., Priestman, D. A., Mistry, S. C., & Halsall, A. (1994) · Diabetologia · doi:10.1007/bf00400839 · Cited by 160
Fanelli, C. G., Calderone, S., Epifano, L., Vincenzo, A. D., Modarelli, F., Pampanelli, S., Perriello, G., Feo, P. D., Brunetti, P., & Gerich, J. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116746 · Cited by 159
Fatty acids and insulin resistance in muscle and liver
Kovacs, P. L., & Stümvoll, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.003 · Cited by 158
Free fatty acids FFA a link between obesity and insulin resistance
Boden, G. H. (1998) · Frontiers in bioscience · doi:10.2741/a272 · Cited by 148
Watt, M. J., & Hoy, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2011 · Cited by 142
Pharmacological Antilipolysis Restores Insulin Sensitivity During Growth Hormone Exposure
Nielsen, S., Møller, N., Christiansen, J. S., & Jørgensen, J. O. L. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2301 · Cited by 136
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117
The metabolic role of growth hormone in humans with particular reference to fasting
Nørrelund, H. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.02.005 · Cited by 111
Newsom, S. A., Everett, A. C., Hinko, A., & Horowitz, J. F. (2013) · Diabetes Care · doi:10.2337/dc12-2606 · Cited by 115
Bajaj, M., Suraamornkul, S., Kashyap, S., Cusi, K., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0224 · Cited by 109
The Second-Meal Phenomenon in Type 2 Diabetes
Jovanović, A., Gerrard, J., & Taylor, R. (2009) · Diabetes Care · doi:10.2337/dc08-2196 · Cited by 107
Beck‐Nielsen, H., ALFORD, F. P., Levin, K., & Schroeder, H. D. (2001) · Diabetologia · doi:10.1007/s001250100545 · Cited by 105
Self-citationNocturnal and Postprandial Free Fatty Acid Kinetics in Normal and Type 2 Diabetic Subjects
Miles, J. M., Wooldridge, D., Grellner, W. J., Windsor, S. L., Isley, W. L., Klein, S., & Harris, W. S. (2003) · Diabetes · doi:10.2337/diabetes.52.3.675 · Cited by 103
Nielsen, S., Schmitz, O., Møller, N., Pøksen, N., Klausen, I. C., Alberti, K. G. M. M., & Mogensen, C. E. (1993) · Diabetologia · doi:10.1007/bf02374502 · Cited by 102
Guillaume-Gentil, C., Assimacopoulos‐Jeannet, F., & Jeanrenaud, B. (1993) · Diabetologia · doi:10.1007/bf02374470 · Cited by 94
A systematic review of metabolite profiling in gestational diabetes mellitus
Huynh, J., Xiong, G. X., & Bentley–Lewis, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3371-0 · Cited by 99
Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
Elhassan, Y., Philp, A., & Lavery, G. G. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00092 · Cited by 93
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Yabuki, C., Komatsu, H., Tsujihata, Y., Risa, M., Ito, R., Kae, M.-N., Sakuma, K., Miyawaki, K., Kikuchi, N., Takeuchi, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076280 · Cited by 94
van Loon, L. J. C., Thomason-Hughes, M., Constantin‐Teodosiu, D., Koopman, R., Greenhaff, P. L., Hardie, D. G., KEIZER, H. A., Saris, W. H. M., & Wagenmakers, A. J. M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00092.2005 · Cited by 86
Pires, J., Pescara, J. B., & Grummer, R. R. (2007) · Journal of Dairy Science · doi:10.3168/jds.2007-0146 · Cited by 84
Lipid-dependent control of hepatic glycogen stores in healthy humans
Stingl, H., Krššák, M., Krebs, M., Bischof, M. G., Nowotny, P., Fürnsinn, C., Shulman, G. I., Waldhäusl, W., & Roden, M. (2001) · Diabetologia · doi:10.1007/s001250051579 · Cited by 81
The second-meal phenomenon is associated with enhanced muscle glycogen storage in humans
Jovanović, A., Leverton, E., Solanky, B., Ravikumar, B., Snaar, J. E. M., Morris, P. G., & Taylor, R. (2009) · Clinical Science · doi:10.1042/cs20080542 · Cited by 78
Hong, S., Song, W., Zushin, P. H., Liu, B., Jedrychowski, M. P., Mina, A. I., Deng, Z., Čabarkapa, D., Hall, J. A., Palmer, C. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.012 · Cited by 77
Solomon, T. P. J., Haus, J. M., Marchetti, C. M., Stanley, W. C., & Kirwan, J. P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00220.2009 · Cited by 75
Wymelbeke-Delannoy, V. V., LOUIS-SYLVESTRE, J., & Fantino, M. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.620 · Cited by 71
Sharma, D., Narasimhan, B., Kumar, P., & Jalbout, A. F. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.06.009 · Cited by 70
Worm, D., Henriksen, J. E., Vaag, A. A., Thye‐Rønn, P., Melander, A., & Beck‐Nielsen, H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126147 · Cited by 65
Self-citationSatiety power of dietary fat: a new appraisal
Himaya, A., Fantino, M., Antoine, J., Brondel, L., & LOUIS-SYLVESTRE, J. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1410 · Cited by 64
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 76
Vaag, A. A., ALFORD, F. P., Henriksen, F. L., Christopher, M., & Beck‐Nielsen, H. (1995) · Diabetologia · doi:10.1007/bf00400638 · Cited by 58
Self-citationMetabolic and behavioral consequences of a snack consumed in a satiety state
Marmonier, C., Chapelot, D., & LOUIS-SYLVESTRE, J. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.5.854 · Cited by 62
Internalization of the Human Nicotinic Acid Receptor GPR109A Is Regulated by Gi, GRK2, and Arrestin3
Li, G., Shi, Y., Huang, H., Zhang, Y., Wu, K., Luo, J., Sun, Y. E., Lü, J., Benovic, J., & Zhou, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087213 · Cited by 53
Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management
Pontiroli, A. E., Caiderara, A., & Pozza, G. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100104 · Cited by 53
7 Insulin action and substrate competition
Groop, L., & Ferrannini, E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80243-5 · Cited by 51
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 51
Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack
Chen, M. J., Jovanović, A., & Taylor, R. (2010) · Diabetes Care · doi:10.2337/dc10-0552 · Cited by 49
Ernsberger, P. R., Ishizuka, T., Liu, S., Farrell, C. J., Bedol, D., Koletsky, R. J., & Friedman, J. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37935-2 · Cited by 49
Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis
Lucidi, P., Rossetti, P., Porcellati, F., Pampanelli, S., Candeloro, P., Andreoli, A. M., Perriello, G., Bolli, G. B., & Fanelli, C. G. (2010) · Diabetes · doi:10.2337/db09-0745 · Cited by 47
Riemens, S. C., Sluiter, W. J., & Dullaart, R. P. F. (2000) · Diabetologia · doi:10.1007/s001250051324 · Cited by 46
Beck‐Nielsen, H., Nielsen, O. H., Vaag, A. A., & ALFORD, F. P. (1994) · Diabetologia · doi:10.1007/s001250050097 · Cited by 42
Self-citationAcipimox enhances spontaneous growth hormone secretion in obese women
Kok, P., Buijs, M. M., Kok, S. W., van Ierssel, I. H. A. P., Frölich, M., Roelfsema, F., Voshol, P. J., Meinders, A. E., & Pijl, H. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00595.2003 · Cited by 41
Saloranta, C., Groop, L., Ekstrand, A., Franssila-Kallunki, A., Eriksson, J., & Taskinen, M. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00011.x · Cited by 34
Nørrelund, H., Djurhuus, C., Jørgensen, J. O. L., Nielsen, S., Nair, K. S., Schmitz, O., Christiansen, J. S., & Møller, N. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00092.2003 · Cited by 39
Bajaj, M., Medina-Navarro, R., Suraamornkul, S., Meyer, C., DeFronzo, R. A., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-0840 · Cited by 38
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1 · Cited by 37
Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes
Højlund, K., Poulsen, M. K., Stæhr, P., Brusgaard, K., & Beck‐Nielsen, H. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01098.x · Cited by 37
Self-citationMcCarty, M. F. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90243-1 · Cited by 37
Metabolism of energy-yielding substrates in patients with liver cirrhosis
M�ller, M. J., ker, K. H. W. B., & Selberg, O. (1994) · Journal of Molecular Medicine · doi:10.1007/bf00227447 · Cited by 35
Nørrelund, H., Nielsen, S., Christiansen, J., Jørgensen, J. O. L., & Møller, N. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500779 · Cited by 33
Rattarasarn, C. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2005.01521.x · Cited by 34
Reduced plasma free fatty acid availability during exercise: effect on gene expression
Tunstall, R. J., McAinch, A. J., Hargreaves, M., van Loon, L. J. C., & Cameron‐Smith, D. (2006) · European Journal of Applied Physiology · doi:10.1007/s00421-006-0376-5 · Cited by 31
Piatti, P., Monti, L. D., Davis, S. N., Conti, M., Brown, M. D., Pozza, G., & Alberti, K. G. M. M. (1996) · Diabetologia · doi:10.1007/bf00400420 · Cited by 31
Wang, M., & Fotsch, C. H. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.010 · Cited by 30
Shih, K., Kwok, C., Hwu, C., Hsiao, L.-C., Li, S.-H., Liu, Y.-F., & Ho, L.-T. (1997) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(97)00039-9 · Cited by 29
Lim, E. L., Hollingsworth, K. G., Smith, F. E., Thelwall, P. E., & Taylor, R. (2011) · Clinical Science · doi:10.1042/cs20100611 · Cited by 28
Lindegaard, B., Frøsig, C., Petersen, A. M. W., Plomgaard, P., Ditlevsen, S., Mittendorfer, B., van Hall, G., Wojtaszewski, J. F. P., & Pedersen, B. K. (2007) · Diabetes · doi:10.2337/db07-0144 · Cited by 27
Lee, K., Park, J. Y., Kim, C. H., Hong, S. K., Suh, K. I., Park, K. S., & Park, S. W. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90123-7 · Cited by 27
Féry, F., Plat, L., Balériaux, M. L., & Balasse, E. O. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3821 · Cited by 27
Fulcher, G. R., Walker, M., Farrer, M., Johnson, A.-L., & Alberti, K. G. M. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90079-4 · Cited by 27
Effect of lipid oxidation on glucose utilization in humans
Jéquier, E. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.527s · Cited by 25
Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes
Brøns, C., & Vaag, A. A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.177758 · Cited by 25
Self-citationAxelsen, M., Lönnroth, P., Lenner, R. A., Taskinen, M., & Smith, U. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1108 · Cited by 24
Hepatic glucose production: therapeutic target in type 2 diabetes?
Stæhr, P., Nielsen, O. H., & Beck‐Nielsen, H. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00177.x · Cited by 25
Self-citationHulin, B. (1994) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70018-3 · Cited by 23
Walker, M., Agius, L., Ørskov, H., & Alberti, K. G. M. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90219-e · Cited by 23
Kinetics and utilization of lipid sources during acute exercise and acipimox
Nellemann, B., Søndergaard, E., Jensen, J., Pedersen, S. B., Jessen, N., Jørgensen, J. O. L., & Nielsen, S. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00043.2014 · Cited by 19
Nutrient effects: post-absorptive interactions
Jéquier, E. (1995) · Proceedings of The Nutrition Society · doi:10.1079/pns19950052 · Cited by 19
Worm, D., Vinten, J., Vaag, A. A., Henriksen, J. E., & Beck‐Nielsen, H. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430389 · Cited by 19
Self-citationGougeon, R. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.1.78 · Cited by 19
Davoren, P. M., Kelly, W., Gries, F. A., Hübinger, A., Whately‐Smith, C., & Alberti, K. G. M. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90252-9 · Cited by 17
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Campelj, D. G., & Philp, A. (2022) · Sports Medicine · doi:10.1007/s40279-022-01772-2 · Cited by 20
Effects of Benfluorex on Fatty Acid and Glucose Metabolism in Isolated Rat Hepatocytes
Kohl, C., Ravel, D., Girard, J. R., & Pégorier, J. P. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2363 · Cited by 16
Impact of moderate exercise on fatty acid oxidation in pancreatic β-cells and skeletal muscle
Langlois, A., Forterre, A. V., Pinget, M., & Bouzakri, K. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01551-2 · Cited by 18
Carey, P. E., Gerrard, J., Cline, G. W., Man, C. D., English, P. T., Firbank, M., Cobelli, C., & Taylor, R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2005 · Cited by 14
Nielsen, S., Møller, N., Pedersen, S. B., Christiansen, J. S., & Jørgensen, J. O. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8597 · Cited by 13
Nicotinic Acid and Derivatives
OLSSON, A. G. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78426-2_13 · Cited by 12
Obeid, O., & Emery, P. W. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514559 · Cited by 12
Jenkins, A. B., Storlien, L. H., Cooney, G. J., Denyer, G. S., Caterson, I. D., & Kraegen, E. W. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.4.e592 · Cited by 11
Green, J. G., Johnson, N. A., Sachinwalla, T., Cunningham, C. W., Thompson, M. W., & Stannard, S. R. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.013 · Cited by 11
1 Insulin action, thermogenesis and obesity
Cooney, G. J., & Storlien, L. H. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80283-6 · Cited by 10
Hannah, J. S., Bodkin, N. L., Paidi, M., Anh-Le, N., Howard, B. V., & HANSEN, B. C. (1995) · Acta Diabetologica · doi:10.1007/bf00576264 · Cited by 10
Regulation of skeletal muscle carbohydrate oxidation during steady-state contraction
Timmons, J. A., Poucher, S. M., Constantin‐Teodosiu, D., Macdonald, I. A., & Greenhaff, P. L. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.5.r1384 · Cited by 9
Bryson, J. M., Cooney, G. J., Wensley, V. R., Phuyal, J. L., & Caterson, I. D. (1995) · Biochemical Journal · doi:10.1042/bj3050811 · Cited by 7
Regulation of Adipose Tissue Lipolysis, Importance for the Metabolic Syndrome
Arner, P. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2910-1_19 · Cited by 7
Metadata
- Authors
- Vaag, A., Skött, P., Damsbo, P., Gall, M. A., Richter, E. A., & Beck-Nielsen, H.
- Affiliations
- Odense University Hospital (DK)
- University of Copenhagen (DK)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1991-10-01
- Volume
- 88
- Issue
- 4
- Pages
- 1282-1290
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1987680714
- Cited by
- 123
- References
- 64
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Diabetesforeningen
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- acipimox, type 2 diabetes, skeletal muscle glucose metabolism, insulin-stimulated glucose disposal, free fatty acids, lipolysis inhibition, lipid oxidation, glucose oxidation, glycogen synthase, insulin resistance, vastus lateralis, nonoxidative glucose disposal, pyruvate dehydrogenase, phosphofructokinase, glucose-6-phosphate
- MeSH terms
- Hypolipidemic Agents, Biological Transport, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Glycogen Synthase, Humans, Lactates, Middle Aged, Muscles, Oxidation-Reduction, Pyrazines, Pyruvate Dehydrogenase Complex, Lactic Acid, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review